Trial Of Experimental TB Drug First In 6 Years, Revealing Poor State Of Research On Disease

Devex: New TB drug enters first trial: The good and sad news
“The maiden human trial of a potential tuberculosis drug — the first in six years — has now commenced. Known as TBA-354, the promising drug comes from a class of chemicals known to be effective against drug-sensitive and drug-resistant tuberculosis, deemed a major public health concern because it can derail progress made in TB treatment and care. … Although considered a milestone, this news also hints at the sad state of research and development for TB drugs…” (Villarino, 2/19).